Edwards Lifesciences Corporation
EW
$81.83
$0.670.83%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.46% | 1.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.46% | 1.94% | |||
| Cost of Revenue | 14.19% | 3.22% | |||
| Gross Profit | 6.90% | 1.60% | |||
| SG&A Expenses | 7.79% | -5.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -11.52% | 15.86% | |||
| Total Operating Expenses | 9.82% | -2.82% | |||
| Operating Income | 5.12% | 15.82% | |||
| Income Before Tax | -7.77% | 11.23% | |||
| Income Tax Expenses | -8.53% | 55.88% | |||
| Earnings from Continuing Operations | -7.62% | 5.39% | |||
| Earnings from Discontinued Operations | 38.89% | -118.32% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 6.25% | 23.08% | |||
| Net Income | -6.93% | -7.16% | |||
| EBIT | 5.12% | 15.82% | |||
| EBITDA | 5.04% | 12.61% | |||
| EPS Basic | -6.95% | -6.70% | |||
| Normalized Basic EPS | 3.69% | 16.22% | |||
| EPS Diluted | -7.45% | -7.04% | |||
| Normalized Diluted EPS | 3.70% | 16.19% | |||
| Average Basic Shares Outstanding | 0.02% | -0.49% | |||
| Average Diluted Shares Outstanding | 0.02% | -0.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||